Amicus Therapeutics Inc (FOLD)

Cost of Revenue

$28.44M

Quarterly · Period ending: · USD

FOLD logo

FOLD Cost of Revenue

Latest reported$28.44M
FOLD Quarterly Cost of Revenue ($0.00 → $28.44M)
High-resolution chart · PNG

FOLD cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amicus Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
28,444,000
21,341,000
15,217,000
11,698,000
14,836,000
13,279,000
11,261,000
13,567,000
11,324,000
9,946,000
9,114,000
6,942,000
9,384,000
13,436,000
8,197,000
7,582,000
7,851,000
11,696,000
8,380,000
6,539,000
9,417,000
8,399,000
6,676,000
6,552,000
6,945,000
5,596,000
5,367,000
4,055,000
4,344,000
4,310,000
3,135,000
2,615,000
2,610,000
1,790,000
1,061,000
775,000
489,000
344,000
0
0
0
0
8,740,000
8,307,000
8,167,000
5,915,000
4,181,000
4,112,000
2,857,000
3,664,000
2,938,000
4,134,000
3,866,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.